1. Introduction {#sec1}
===============

Tendon injuries debilitate numerous people in athletic and occupational surroundings and remain a clinical challenge \[[@B1]--[@B3]\]. Injured tendon tissue heals very slowly, especially flexor tendons in the hand which is one of the most common injuries in upper extremity \[[@B4]--[@B6]\]. Clayton and Court-Brown studied 2794 tendinous or ligamentous injuries and found that hand tendon injuries accounted for over 1/3 of all cases \[[@B1]\]. Surgical interventions following flexor tendon injury are needed to restore function \[[@B7], [@B8]\] but often associated with inferior structural integrity and mechanical strength \[[@B9], [@B10]\]. Currently, stem cell-mediated approaches play a crucial role in regeneration medicine to improve the outcome of tendon injuries \[[@B11]--[@B14]\]. Mesenchymal stem cells (MSCs) possess clonogenicity, multipotency, and high proliferative capacity. MSCs are capable of adhering to plastic culture and can differentiate towards osteogenic, chondrogenic, and adipogenic lineages \[[@B15]\]. Therefore, MSCs serve as a favorable cell source for applications in the field of regenerative medicine and tissue engineering. MSCs can be isolated from several tissues such as synovium \[[@B16]\], umbilical cord \[[@B17]\], adipose \[[@B18]\], cartilage \[[@B19]\], and periosteum \[[@B20]\] but most commonly from bone marrow \[[@B21]\] and adipose tissue \[[@B22]\].

In addition to MSCs from bone marrow \[[@B11], [@B13], [@B14]\], tendon-derived stem cells (TDSCs) are emerging as a better candidate for application in tissue regenerative medicine \[[@B23]--[@B25]\]. TDSCs are a unique cell population present within the tendon tissues that have self-renewal and multilineage differential potential \[[@B26]\]. Compared with bone marrow-derived stem cells (BMSCs), TDSCs have been demonstrated to form more colonies, proliferate faster, and exhibit higher multilineage differentiation potential \[[@B26]--[@B28]\]. Moreover, TDSCs have been found to express tenogenic markers with increased collagen synthesis in cell culture, which makes them superior for tendon injuries repair than BMSCs \[[@B29]\].

Canine and chicken are currently the most popular animal models for flexor tendon-related research. However, they have several disadvantages that demand development of a new large animal model \[[@B30]\]. The canine model disadvantages include the cost and concerns regarding companion animal use. Although the chicken model is more affordable and has similarity to human vasculature \[[@B31], [@B32]\], it is complicated by an additional phalanx in the third digit and difficulties in postoperative rehabilitation \[[@B33]\]. Recently, our group has shown that turkey flexor tendons have many similarities such as anatomy and biomechanical properties to human flexor tendons, which would make the turkey a potential new large animal model for clinically relevant flexor tendon research \[[@B34]\]. The ability to identify turkey TDSCs would pave the way for studies on its role in tendon physiology and tendinopathy and open up new treatment for tendon diseases.

In this study, the isolation and verification of stem cells from heritage-breed turkeys\' flexor tendon are evaluated. We assessed TDSCs\' ability to form colonies, proliferative capacity, and morphology change. Stem cell markers were examined by electrophoresis. The multilineage potential of TDSCs was investigated by histological assay and gene expression analysis.

2. Materials and Methods {#sec2}
========================

2.1. Turkey TDSC Isolation and Expansion {#sec2.1}
----------------------------------------

Three 6- to 8-month-old heritage-breed turkeys, weighing 8--10 kg, were used for the isolation of TDCSs. All animal protocols were approved by our Institutional Animal Care and Use Committee (IACUC). After euthanasia, the intact flexor digitorum profundus (FDP) tendon in the zone II area where the tendon is located within the flexor sheath was dissected out from the third digit of each turkey. The tendon sheath and peritendinous tissue were carefully removed. The tendon midsubstance was then gently cut into small pieces and digested with collagenase type I (Sigma-Aldrich, St. Louis, MO) at the concentration of 3 mg/ml for 2.5 h at 37°C and filtered through a 70 *μ*m cell strainer (BD Falcon, Bedford, MA) to remove undigested tissue. After centrifugation at 300*g* for 5 min, the cell pellet was resuspended in Dulbecco\'s modified Eagle\'s medium (DMEM; Gibco, Carlsbad, CA) containing 1% antibiotics (antibiotic--antimycotic; Gibco) and 10% fetal bovine serum (FBS). The cells were plated in 100 mm Corning® dishes at a low density (500 cells/cm^2^) and cultured at 37°C with 5% CO~2~. Nonadherent cells were removed with PBS wash after 48 h of plating. The medium was changed every 3 days. When the cultured primary cells reached 70%--80% confluence, they were subcultured after digestion with 0.25% trypsin/1 mM EDTA and used for further studies.

2.2. Colony-Forming Unit (CFU) Assay {#sec2.2}
------------------------------------

For the isolation of stem cells from tendon, the optimal cell seeding density was determined by culturing nucleated cells obtained from turkey flexor tendon in 6-well plates at 50, 500, and 5000 cells/cm^2^ and the procedure was repeated in triplicate. 10 days after culture, the cells were stained with 0.5% crystal violet (Sigma, St. Louis, MO) after fixation with 4% paraformaldehyde to quantify the colony formation. Colonies larger than 2 mm in diameter and were distinguishable were included for counting. The optimal cell seeding density was determined based on the largest number of colonies obtained without contact inhibition between colonies \[[@B35]\]. The percentage of tendon-derived stem cells was calculated by dividing the colony number at the optimal seeding density by the nucleated cell number.

2.3. Cell Proliferation of Turkey TDSCs {#sec2.3}
---------------------------------------

P3 tendon-derived cells were plated in 12-well plates at 5000 cells/cm^2^ in triplicate and cultured at 37°C, 5% CO~2~. Cell proliferation was evaluated every 2 days until day 12 after cell seeding. Viable cells were determined by using Trypan blue staining. The proliferative potential of cells was presented in relative fold change.

2.4. RNA Isolation and Gene Expression {#sec2.4}
--------------------------------------

The gene expression of osteogenic, adipogenic, and chondrogenic markers after induction and embryonic stem cell (ESC) markers at different cell passages was examined by quantitative real-time polymerase chain reaction (qRT-PCR). The mRNA expression of tendon-related markers was also examined. Total RNA was isolated using TRIzol® reagent (Invitrogen, Grand Island, NY) per the manufacturer\'s protocol. RNA concentration was assessed by absorbance at 260 and 280 nm with a DS-11 spectrophotometer (DeNovix, Wilmington, DE). Complementary DNA (cDNA) was synthesized from equal amounts of RNA (1 *μ*g) using the iScript™ cDNA Synthesis Kit (Bio-Rad). All reactions were performed using SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA) on a C1000 Touch™ Thermal Cycler (Bio-Rad Laboratories, Hercules, CA) for the following genes: scleraxis (*SCX*), mohawk (*MKX*), tenomodulin (*TNMD*), thrombospondin-4 (*THBS4*), tenascin C (*TNC*), collagen type I (*COL1A1*), decorin (*DCN*), elastin (*ELN*), peroxisome proliferator-activated receptor (*PPARγ*), adipocyte-binding protein 2 (*aP2*), runt-related transcription factor 2 (*RUNX2*), osteopontin (*SPP1*), osteocalcin (*BGLAP*), sex-determining region Y-box9 (*SOX9*), collagen type II (*COL2A1*), aggrecan (*ACAN*), *PouV*, *Nanog*, and *Sox2*. The cycling program was 2 min at 95°C, then 40 cycles of amplifications, 5 s at 95°C for denaturation, 5 s at 65°C for annealing, and 5 s at 95°C for extension. PCR primers were designed using Primer3 version 0.4.0 software ([Table 1](#tab1){ref-type="table"}). All primers were from chicken. Each sample was analyzed in triplicate. The gene expression level of the target genes was normalized to *GAPDH* and then analyzed by the 2^−∆Ct^ formula with reference to the noninduced controls. The experiment was performed in duplicates of cells from two turkeys.

2.5. MSC Marker Analysis {#sec2.5}
------------------------

MSC surface markers, including CD90, CD105, and CD44, were examined as previously described \[[@B36]\]. Hematopoietic cell marker CD45 was also examined to exclude the contamination of hematopoietic cells. Briefly, a total of 10 *μ*L amplified DNA fragments were electrophoresed on a 1.5% agarose gel to detect PCR products for each marker.

2.6. Multidifferentiation Potential {#sec2.6}
-----------------------------------

We investigated the multipotency of P3 turkey tendon-derived cells based on the method of Pittenger et al. \[[@B37]\] and Scharstuhl et al. \[[@B38]\] with minor modifications.

### 2.6.1. Osteogenic Differentiation {#sec2.6.1}

Tendon-derived cells were cultured in complete medium in a six-well plate at a density of 4 × 10^3^ cells/cm^2^. Osteogenesis was tested by inducing the cells in osteogenic differentiation medium (Gibco; StemPro® Osteogenesis Differentiation Kit) for 3 weeks. Control groups were cultured in basal complete media. The medium was refreshed every 3--4 days. To assess osteogenesis, calcium nodules were stained with Alizarin Red S after 21 days, and the osteogenic lineage-specific gene expressions (*RUNX2*, *SPP1*, and *BGLAP*) were assessed using qRT-PCR. Alizarin Red S staining was conducted by washing the cells with PBS, then fixed with 70% ethanol for 10 min, and incubated with 0.5% Alizarin Red S (pH 4.1; Sigma-Aldrich) for 30 min. Images of stained cells were obtained using a light microscope (BH2, Olympus).

### 2.6.2. Adipogenic Differentiation {#sec2.6.2}

Tendon-derived cells were cultured in complete medium in a six-well plate at a density of 4 × 10^3^ cells/cm^2^. When cells reached 100% confluence, adipogenesis was induced by replacing basal medium with adipogenic differentiation medium (Gibco; StemPro Adipogenesis Differentiation Kit). After three weeks, the gene expression of adipogenic markers (*PPARγ*, *aP2*) and the accumulation of lipid droplets were assessed by qRT-PCR and Oil red-O (Sigma-Aldrich) staining, respectively. Cells cultured in basal complete medium only served as control. Fresh medium was fed to cultures every 3--4 days. Oil red-O staining was completed. Cells were washed two times with dH~2~O; filtered 0.3% Oil red-O solution was added and incubated for 15 min after fixed with 70% ethanol for 20 s. Cultures were washed with PBS three times, hematoxylin was added, and cells were incubated for 30 s. Images of stained cells were viewed using a light microscope (BH2, Olympus).

### 2.6.3. Chondrogenic Differentiation {#sec2.6.3}

Micromass culture was used for inducing chondrogenesis. Briefly, 5 *μ*L droplets of cell solution were seeded in the center of 24-well plates after resuspending cells in chondrogenic differentiation medium (Gibco; StemPro Chondrogenesis Differentiation Kit) at 1.6 × 10^7^ cells/mL. After incubating for 2 hours, a 500 *μ*L chondrogenic differentiation medium (Gibco; StemPro Chondrogenesis Differentiation Kit) was added. Cultures were fed every 2--3 days. After 21 days of culture, the micromass was rinsed with PBS and fixed in 4% paraformaldehyde for 30 min. The micromass was then stained with 1% Alcian blue solution to evaluate glycosaminoglycan synthesis. The gene expressions of *COL2A1*, *SOX9*, and *ACAN* were assessed using qRT-PCR as described above.

3. Data Analysis {#sec3}
================

All data are presented as mean ± standard deviation. Comparison of two groups was done using two-tailed, unpaired Student\'s *t*-test, and the comparison of multiple groups was done using one-way factorial analysis of variance (ANOVA) followed by comparison of individual means with Tukey\'s test. Statistical analyses were performed with SPSS statistical software (version 17.0, SPSS Inc., Chicago, IL). *P* \< 0.05 was regarded as statistically significant.

4. Results {#sec4}
==========

4.1. Clonogenicity and Proliferation of Tendon-Derived Cells {#sec4.1}
------------------------------------------------------------

The clonogenic capacity of tendon-derived cells was assessed using *CFU* assay. After 10 days, cells isolated from tendon formed adherent cell colonies ([Figure 1(a)](#fig1){ref-type="fig"}). The optimal cell seeding density was determined by plating cells isolated from turkey tendon at several densities. We found that at 5000 cells/cm^2^, the colonies were indistinguishable. The number of colonies was significantly higher when plating at 500 cells/cm^2^ compared to that at 50 cells/cm^2^ (198 ± 15.7 colonies versus 39 ± 1.5 colonies, *n* = 3, *P* \< 0.01) ([Figure 1(b)](#fig1){ref-type="fig"}). Approximately 4% of tendon-derived nucleated cells were able to form colonies. The proliferation profile of tendon-derived cells was assessed by counting viable cells for 12 days at a 2-day interval using Trypan blue exclusion method. The cells demonstrated a more than 25-fold increase with time up to day 12, indicating that the tendon-derived cells possessed high proliferative capability ([Figure 1(c)](#fig1){ref-type="fig"}).

4.2. Cell Morphology of Tendon-Derived Cells {#sec4.2}
--------------------------------------------

Spindle-shaped and polygonal cells were both found at P0. At P1, cells demonstrated spindle-shaped fibroblastic morphology. The majority of cells at P3 retained fibroblast-like morphology [Figure 2(a)](#fig2){ref-type="fig"}).

4.3. Phenotype of Tendon-Derived Cells {#sec4.3}
--------------------------------------

The expression of MSC phenotypic markers was evaluated using RT-PCR ([Figure 2(b)](#fig2){ref-type="fig"}). Our results showed that the tendon-derived cells expressed surface antigens CD44, CD90, and CD105, but not CD45, thus indicating the mesenchymal lineage origin of these cells.

4.4. Expression of PouV, Nanog, and Sox2 Transcription Factors {#sec4.4}
--------------------------------------------------------------

The gene expression of *PouV*, *Nanog*, and *Sox2* was detected up to passage 10. P8 cells expressed higher levels of *Sox2* (*P* = 0.011) than did P3 cells. No significant difference was found in the mRNA expression of *PouV* (*P* = 0.792) or *Nanog* (*P* = 0.136) between different passages ([Figure 2(c)](#fig2){ref-type="fig"}).

4.5. Expression of Tenogenic Markers {#sec4.5}
------------------------------------

The gene expression level of tendon-related markers was examined by qRT-PCR. The isolated turkey TDSCs had high mRNA expression level of *MKX*, *COL1A1*, *TNC*, and *ELN* ([Figure 3](#fig3){ref-type="fig"}).

4.6. Osteogenic Differentiation Potential {#sec4.6}
-----------------------------------------

After 21 days of osteogenic induction, Alizarin Red S assay demonstrated that induction cultures had calcium nodules ([Figure 4(a)](#fig4){ref-type="fig"}), which were absent in the basal cultures ([Figure 4(b)](#fig4){ref-type="fig"}). The mRNA expression level of *RUNX2* (*P* = 0.0028), *SPP1* (*P* ≤ 0.001), and *BGLAP* (*P* = 0.011) was also upregulated after 21 days of incubation in osteogenic medium ([Figure 4(c)](#fig4){ref-type="fig"}).

4.7. Adipogenic Differentiation Potential {#sec4.7}
-----------------------------------------

Oil red-O staining showed lipid droplet accumulation within the cells upon adipogenic induction for 3 weeks ([Figure 5(a)](#fig5){ref-type="fig"}). This was absent in the control group ([Figure 5(b)](#fig5){ref-type="fig"}). The gene expression level of *aP2* (*P* ≤ 0.001) was significantly upregulated, whereas there was a trend of increased expression of *PPARγ* (*P* = 0.075) after adipogenic differentiation for 21 days ([Figure 5(c)](#fig5){ref-type="fig"}).

4.8. Chondrogenic Differentiation Potential {#sec4.8}
-------------------------------------------

After 21 days of chondrogenic induction, there was glycosaminoglycan deposition found in micromass by Alcian blue staining ([Figure 6(a)](#fig6){ref-type="fig"}). There was increased gene expression of *COL2A1* (*P* = 0.03), whereas expression of *SOX9* showed a trend (*P* = 0.071) to increase after chondrogenic induction for 3 weeks ([Figure 6(c)](#fig6){ref-type="fig"}). The ethidium bromine gel showed a thick band for induction culture and no *ACAN* expression for basal culture ([Figure 6(b)](#fig6){ref-type="fig"}).

5. Discussion {#sec5}
=============

This study demonstrated that turkey flexor tendon harbors a population of cells that has stem cell characteristics. Using methods previously described \[[@B23], [@B24], [@B35]\], we have isolated for the first time multipotent cells from the turkey flexor tendon. The cells were plastic adherent, possessed high proliferative potential, and were able to form colonies and have multilineage potential. When plating at 500 cells/cm^2^, about 4% of nucleated cells formed adherent cell colonies. These findings corresponded well with previous studies that have shown plating cells at low density allowing the selective expansion of stem cells from tendon \[[@B23], [@B35]\]. Furthermore, the percentage of stem cells was comparable to that shown in previous studies \[[@B26], [@B35]\]. Bi et al. \[[@B26]\] showed that about 3% to 4% of cells derived from mouse patellar tendons and human hamstring tendons were TDSCs. Rui et al. \[[@B35]\] showed that rat flexor tendons contained approximately 1% to 2% of TDSCs. In contrast, the percentage of MSCs residing in the adult bone marrow is less than 0.01% \[[@B15], [@B37], [@B39]\]. Therefore, tendon could be an alternative tissue for providing sources of MSCs.

Our group has recently compared the turkey flexor tendon to commonly used animal models and human hands \[[@B40]\]. It was found that turkey flexor tendon has more similarities to human than canine and chicken in terms of structure, function, and mechanical properties. Previous assumptions were made that since turkey leg tendons mineralize, their flexor tendons would mineralize likewise and thus would not make an ideal flexor tendon model \[[@B41]--[@B43]\]. However, we have determined that the tendon in the digit is not calcified, which is essential for flexor tendon research. Given that the 3rd digit of the turkey has the most suitable scale for experimentation \[[@B33]\] and zone II flexor tendon injuries are difficult to repair \[[@B6], [@B44]\], we focused our evaluation of the biological potential of these tendons.

The TDSCs isolated from turkey tendon were positive for MSC markers CD44, CD90, and CD105, while lacking expression of CD45 (a marker of all hematopoietic cells) \[[@B45]\]. These phenotypic profiles fulfilled the requirements proposed by the International Society for Cellular Therapy (ISCT) for defining MSCs \[[@B46]\]. Similarly, surface antigens CD44 and CD90 were also seen in mouse and human TDSCs \[[@B26]\] and in rat TDSCs \[[@B35]\]. Currently, there are no known turkey protein antibodies for CD44, CD90, CD105, and CD45 available; we attempted to use rat anti-mouse monoclonal antibodies to examine the phenotype of cells by flow cytometry, but we did not observe species cross-reactions. In addition, turkey TDSCs exhibited high mRNA expression of tenogenic markers, including *MKX*, *COL1A1*, *TNC*, and *ELN*. *MKX* is essential for tendon differentiation and collagen fibril maturation \[[@B47]\]. *COL1A1*, *TNC*, and *ELN* are regarded as major markers of the tendon extracellular matrix \[[@B48]\]. The gene expression of embryonic stem cell markers, including *PouV*, *Nanog*, and *Sox2* in TDSCs, were also evaluated. *PouV* is a homologue of *Oct4* in mammals and plays a key role in regulating chicken embryonic stem cell stemness \[[@B49]\]. *Nanog* and *Sox2* are also involved in the maintenance of stemness in undifferentiated embryonic stem cells \[[@B50], [@B51]\]. Our results showed that the expression of *PouV*, *Nanog*, and *Sox2* were detected in turkey TDSCs up to 10 passages *in vitro* without significantly reduced expression. This was comparable with previous studies that gene expressions of *PouV*, *Nanog*, and *Sox2* can be detected up to passage 8 in chicken BMSCs \[[@B36]\]. This is further indication that TDSCs maintain stem characteristics. The increased *Sox2* expression in P8 cells could be postulated as a result of the enrichment of stem cells with *in vitro* expansion while preserving their stemness. It has been suggested that current methods are incapable of isolating pure TDSCs at the early passage stage \[[@B52]\]. With the passage increased, the population of stem cells increased relative to the non-stem-cell population. Moreover, TDSCs from rat patellar tendons demonstrated higher clonogenicity with *in vitro* passaging \[[@B53]\], indicating that cell subculture might lead to increased expression of *Sox2* which is critical for MSC self-renewal capacity \[[@B54]\].

To characterize the multipotency of the turkey TDSCs, we differentiated the tendon-derived cells for osteogenesis, chondrogenesis, and adipogenesis and found that tendon-derived cells had multilineage capacity. Further, we evaluated the gene expression of lineage-specific markers for trilineage differentiation. Differentiation of TDSCs into osteogenic lineage was confirmed by matrix mineralization and significant upregulation of bone markers *SPP1*, *RUNX2*, and *BGLAP*. Furthermore, adipogenic differentiation was shown by Oil red-O staining of lipid droplets within cells and by increases in *aP2* gene expression, which is a late marker for adipocyte \[[@B55]\] but not *PPARγ*, which induced early during adipocyte differentiation \[[@B56]\]. The chondrogenic potential of TDSCs was demonstrated by synthesis of proteoglycans using Alcian blue stain analysis. The expression of *COL2A1* and *ACAN* (major cartilage extracellular matrix components) \[[@B57]\] was upregulated but not *SOX9*, an early marker for chondrogenesis \[[@B58]\] in micromass cultures. Our findings regarding expression of *PPARγ* and *SOX9* were different from previous studies by Rui et al. \[[@B35]\] who found an upregulation of *PPARγ* and *SOX9* in rat TDSCs after adipogenic and chondrogenic induction, respectively. However, the negative feedback mechanisms as well as different species might account for the differences.

In conclusion, we have for the first time isolated and shown that TDSCs from turkey exhibit clonogenicity, MSC marker expression, and multilineage differentiation potential. The successful isolation of tendon-derived stem cells from turkey should prove to be an important model system for future research in tendon tissue engineering in terms of structure, function, and biology.
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![(a) Colony-forming unit assay of tendon-derived cells after 10 days of culture at 50, 500, and 5000 cells/cm^2^. (b) Number of cell colonies when tendon-derived cells were plated at 50 or 500 cells/cm^2^. *n* = 3, ^∗^*P* \< 0.01. (c) Graph showing the proliferative over time of tendon-derived cells at P3. The results shown here were mean ± standard deviation of three wells for each time point. The experiment was performed independently in two turkeys.](SCI2018-3697971.001){#fig1}

![(a) Photomicrographs show different cell morphologies at different passages. At P0, spindle-shaped and polygonal cells were observed, and P1 cells demonstrated spindle-shaped fibroblastic morphology. At P3, homogeneous fibroblast-like cells were observed. Scale bars: 200 *μ*m. (b) Phenotype of tendon-derived cells. RT-PCR was performed using total RNA extracted from P3 cells. The right column shows the results with total RNA from TDSCs. Total RNA extracted from turkey white blood cells was used as a control (left column). (c) Gene expression analysis of embryonic stem cell markers *PouV*, *Nanog*, and *Sox2* at different cell passages. ^∗^*P* \< 0.05 as compared to P3 cells.](SCI2018-3697971.002){#fig2}

![Scatter plot showing the mRNA expression of eight tendon-related genes in turkey TDSCs. The horizontal bar represents the mean cycle threshold (Ct) value of each gene. *GAPDH* serves as endogenous control. *SCX*: scleraxis; *MKX*: mohawk; *TNMD*: tenomodulin; *THBS4*: thrombospondin-4; *TNC*: tenascin C; *COL1A1*: collagen type I; *DCN*: decorin; *ELN*: elastin.](SCI2018-3697971.003){#fig3}

![Osteogenic induction evaluated with Alizarin red S staining after 21 days in osteogenic media (a) or basal (b) media. Calcium nodules were seen in osteogenic medium (a), but not in basal medium (B). Scale bars: 200 *μ*m; inset, 100 *μ*m. (c) Graph showing the osteogenic gene (*RUNX2*, *SPP1*, and *BGLAP*) expression compared between osteogenic medium and its respective basal cultures. The level of expression of each target gene was normalized to *GAPDH*. ^∗∗^*P* \< 0.01 and ^∗^*P* \< 0.05. *RUNX2*: runt-related transcription factor 2; *SPP1*: osteopontin; *BGLAP*: osteocalcin.](SCI2018-3697971.004){#fig4}

![Adipogenic potential was determined by Oil red-O staining with hematoxylin counterstaining after culturing for 21 days in adipogenic media (a) or basal (b) media. Cytoplasmic lipid droplets were seen in adipogenic medium (a), but not in basal medium (b). Scale bars: 100 *μ*m; inset, 50 *μ*m. (c) Adipogenic gene (*PPARγ* and *aP2*) expression compared between osteogenic medium and its respective basal cultures. The level of expression of each target gene was normalized to *GAPDH*. ^∗^*P* \< 0.01. *aP2*: adipocyte-binding protein 2; *PPARγ*: peroxisome proliferator-activated receptor.](SCI2018-3697971.005){#fig5}

![(a) Chondrogenic potential was evaluated by Alcian blue staining of proteoglycan in micromass pellets after culturing in chondrogenic medium for 21 days. Scale bars: 50 *μ*m. (b) Ethidium bromine gel of *ACAN* showed no expression of *ACAN* products for basal cultures. (c) Chondrogenic gene (*SOX9* and *COL2A1*) expression compared between chondrogenic medium and its respective basal cultures. The level of expression of each target gene was normalized to *GAPDH*. ^∗^*P* \< 0.05. *SOX9*: sex-determining region Y-box9; *COL2A1*: collagen type II; *ACAN*: Aggrecan.](SCI2018-3697971.006){#fig6}

###### 

Sequences of primers used for reverse transcription polymerase chain reaction.

  ----------------------------------------------------------------------------------------
  Gene      Primer   5′-sequence-3′                   Product size (bp)   Accession no.
  --------- -------- -------------------------------- ------------------- ----------------
  GAPDH     Fwd\     TGGGAAGCTTACTGGAATGG\            88                  NM_204305.1
            Rev      CTTGGCTGGTTTCTCCAGAC                                 

  CD44      Fwd\     GGTTTTATAGTGGGGCATATTGTTATCCC\   700                 AF153205
            Rev      TTAACCGCGATGCACACGGC                                 

  CD45      Fwd\     CACTGGGAATCGAGAGGAAA\            574                 NM 204417
            Rev      CTGGTCTGGATGGCACTTTT                                 

  CD90      Fwd\     GGTCTACATGTGCGAGCTGA\            471                 NM 204381
            Rev      AAAGCTAAGGGGTGGGAGAA                                 

  CD105     Fwd\     ACGGATGACACCATGGAAAT\            704                 AY702002
            Rev      ATGAGGAAGGCTCCAAAGGT                                 

  PPAR*γ*   Fwd\     GGATTCATGACACGGGAGTT\            92                  NM_001001460.1
            Rev      GCGTTGAACTTCACAGCAAA                                 

  aP2       Fwd\     GAGTTTGATGAGACCACAGCAGA\         312                 AF432507
            Rev      ATAACAGTCTCTTTGCCATCCCA                              

  RUNX2     Fwd\     CAGGCATGTCACTGGGTATG\            115                 NM_204128.1
            Rev      TATGGAGTGCTGCTGGTCTG                                 

  SPP1      Fwd\     AGCCACCACACACACAGGTA\            87                  M59182.1
            Rev      TGAAGCCAGGTCATTCTGTG                                 

  BGLAP     Fwd\     CGCAGTGCTAAAGCCTTCAT\            140                 NM_205387.1
            Rev      CTCAGCTCACACACCTCTCG                                 

  SOX9      Fwd\     CTCAAGGGCTACGACTGGAC\            141                 NM_204281.1
            Rev      GTACTGGTCAGCCAGCTTCC                                 

  COL2A1    Fwd\     AAGGGTGATCGTGGTGAGAC\            107                 AY046949.1
            Rev      TCGCCTCTGTCTCCTTGTTT                                 

  ACAN      Fwd\     ACTCCCGACACAACATCACA\            101                 NM_204955.2
            Rev      TGCGCTAGTTCAACATCTGG                                 

  PouV      Fwd\     TACATGCCACCTTTCCACAA\            80                  NM_001309372.1
            Rev      CAGTGGCTGCTGTTGTTCAT                                 

  Nanog     Fwd\     TTGGAAAAGGTGGAACAAGC\            140                 NM_001146142.1
            Rev      GGTGCTCTGGAAGCTGTAGG                                 

  Sox2      Fwd\     GCCCTGCAGTACAACTCCAT\            83                  NM_205188.2
            Rev      CCTTGCTGGGAGTACGACAT                                 

  SCX       Fwd\     TCCAGCTACATCTCCCACCT\            145                 NM_204253.1
            Rev      GCTGGGAGTTCTCGGAGTC                                  

  MKX       Fwd\     GTTGGGCTTTGCGAATAAAA\            81                  XM_019616306.1
            Rev      ACGAGTCATCACTGCTCACG                                 

  TNMD      Fwd\     CGGCGAGAAGAAGAAAATTG\            91                  XM_003208349.3
            Rev      CTCCAGGATCTCCTCAGTGC                                 

  THBS4     Fwd\     ATGCTCAGATTGACCCCAAC\            121                 XM_019610190.1
            Rev      CCCTCGAAGTCAACACCATT                                 

  COL1A1    Fwd\     CTGAAGAAGGCTCTGCTGCT\            116                 XM_015273228.1
            Rev      CATGCTCCAGTGTGACTCGT                                 

  TNC       Fwd\     GCCCATGGAGTTCAACATCT\            136                 NM_205456.4
            Rev      TGTAGCCGCAGCACTTATTG                                 

  DCN       Fwd\     CAACACCAAAAAGGCAACCT\            107                 NM_001030747.2
            Rev      CTGCAGAGCGTTCATGGATA                                 

  ELN       Fwd\     TGGCTATAGATTGCCCTTCG\            99                  NM_001293107.1
            Rev      CCAACACCTGTCCCAGTAGG                                 
  ----------------------------------------------------------------------------------------

[^1]: Academic Editor: Andrzej Lange
